Partnership with China prompts change in care for high-risk type of leukemia
(St. Jude Children's Research Hospital) Findings from a collaborative clinical trial have generated key insights into how targeted therapy should be used to treat leukemia driven by the Philadelphia chromosome.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Children | China Health | Clinical Trials | Hospitals | Leukemia | Partnerships